264 related articles for article (PubMed ID: 31124104)
1. Production of Cardiomyocytes from Human Pluripotent Stem Cells by Bioreactor Technologies.
Halloin C; Coffee M; Manstein F; Zweigerdt R
Methods Mol Biol; 2019; 1994():55-70. PubMed ID: 31124104
[TBL] [Abstract][Full Text] [Related]
2. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
3. Continuous WNT Control Enables Advanced hPSC Cardiac Processing and Prognostic Surface Marker Identification in Chemically Defined Suspension Culture.
Halloin C; Schwanke K; Löbel W; Franke A; Szepes M; Biswanath S; Wunderlich S; Merkert S; Weber N; Osten F; de la Roche J; Polten F; Christoph Wollert K; Kraft T; Fischer M; Martin U; Gruh I; Kempf H; Zweigerdt R
Stem Cell Reports; 2019 Aug; 13(2):366-379. PubMed ID: 31353227
[TBL] [Abstract][Full Text] [Related]
4. Generation of human induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer and scalable 3D suspension bioreactor cultures with reduced batch-to-batch variations.
Hamad S; Derichsweiler D; Papadopoulos S; Nguemo F; Šarić T; Sachinidis A; Brockmeier K; Hescheler J; Boukens BJ; Pfannkuche K
Theranostics; 2019; 9(24):7222-7238. PubMed ID: 31695764
[TBL] [Abstract][Full Text] [Related]
5. Cardiac differentiation of human pluripotent stem cells in scalable suspension culture.
Kempf H; Kropp C; Olmer R; Martin U; Zweigerdt R
Nat Protoc; 2015 Sep; 10(9):1345-61. PubMed ID: 26270394
[TBL] [Abstract][Full Text] [Related]
6. Scalable Cardiac Differentiation of Pluripotent Stem Cells Using Specific Growth Factors and Small Molecules.
Kempf H; Zweigerdt R
Adv Biochem Eng Biotechnol; 2018; 163():39-69. PubMed ID: 29071404
[TBL] [Abstract][Full Text] [Related]
7. Large-scale production of human pluripotent stem cell derived cardiomyocytes.
Kempf H; Andree B; Zweigerdt R
Adv Drug Deliv Rev; 2016 Jan; 96():18-30. PubMed ID: 26658242
[TBL] [Abstract][Full Text] [Related]
8. Selection of human induced pluripotent stem cells lines optimization of cardiomyocytes differentiation in an integrated suspension microcarrier bioreactor.
Laco F; Lam AT; Woo TL; Tong G; Ho V; Soong PL; Grishina E; Lin KH; Reuveny S; Oh SK
Stem Cell Res Ther; 2020 Mar; 11(1):118. PubMed ID: 32183888
[TBL] [Abstract][Full Text] [Related]
9. Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors.
Kropp C; Kempf H; Halloin C; Robles-Diaz D; Franke A; Scheper T; Kinast K; Knorpp T; Joos TO; Haverich A; Martin U; Zweigerdt R; Olmer R
Stem Cells Transl Med; 2016 Oct; 5(10):1289-1301. PubMed ID: 27369897
[TBL] [Abstract][Full Text] [Related]
10. Generation of Neural Progenitor Spheres from Human Pluripotent Stem Cells in a Suspension Bioreactor.
Yan Y; Song L; Tsai AC; Ma T; Li Y
Methods Mol Biol; 2016; 1502():119-28. PubMed ID: 26837215
[TBL] [Abstract][Full Text] [Related]
11. Co-culture of induced pluripotent stem cells with cardiomyocytes is sufficient to promote their differentiation into cardiomyocytes.
Chu AJ; Zhao EJ; Chiao M; Lim CJ
PLoS One; 2020; 15(4):e0230966. PubMed ID: 32243463
[TBL] [Abstract][Full Text] [Related]
12. Purification of small molecule-induced cardiomyocytes from human induced pluripotent stem cells using a reporter system.
Hwang GH; Park SM; Han HJ; Kim JS; Yun SP; Ryu JM; Lee HJ; Chang W; Lee SJ; Choi JH; Choi JS; Lee MY
J Cell Physiol; 2017 Dec; 232(12):3384-3395. PubMed ID: 28063225
[TBL] [Abstract][Full Text] [Related]
13. Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture.
Kempf H; Olmer R; Kropp C; Rückert M; Jara-Avaca M; Robles-Diaz D; Franke A; Elliott DA; Wojciechowski D; Fischer M; Roa Lara A; Kensah G; Gruh I; Haverich A; Martin U; Zweigerdt R
Stem Cell Reports; 2014 Dec; 3(6):1132-46. PubMed ID: 25454631
[TBL] [Abstract][Full Text] [Related]
14. Generation and purification of human stem cell-derived cardiomyocytes.
Schwach V; Passier R
Differentiation; 2016; 91(4-5):126-38. PubMed ID: 26915912
[TBL] [Abstract][Full Text] [Related]
15. Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol.
Fonoudi H; Ansari H; Abbasalizadeh S; Blue GM; Aghdami N; Winlaw DS; Harvey RP; Bosman A; Baharvand H
J Vis Exp; 2016 Jul; (113):. PubMed ID: 27500408
[TBL] [Abstract][Full Text] [Related]
16. Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells.
Chen VC; Ye J; Shukla P; Hua G; Chen D; Lin Z; Liu JC; Chai J; Gold J; Wu J; Hsu D; Couture LA
Stem Cell Res; 2015 Sep; 15(2):365-75. PubMed ID: 26318718
[TBL] [Abstract][Full Text] [Related]
17. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.
Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y
Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125
[TBL] [Abstract][Full Text] [Related]
18. Generation of functional cardiomyocytes from rat embryonic and induced pluripotent stem cells using feeder-free expansion and differentiation in suspension culture.
Dahlmann J; Awad G; Dolny C; Weinert S; Richter K; Fischer KD; Munsch T; Leßmann V; Volleth M; Zenker M; Chen Y; Merkl C; Schnieke A; Baraki H; Kutschka I; Kensah G
PLoS One; 2018; 13(3):e0192652. PubMed ID: 29513687
[TBL] [Abstract][Full Text] [Related]
19. Derivation of highly purified cardiomyocytes from human induced pluripotent stem cells using small molecule-modulated differentiation and subsequent glucose starvation.
Sharma A; Li G; Rajarajan K; Hamaguchi R; Burridge PW; Wu SM
J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867738
[TBL] [Abstract][Full Text] [Related]
20. End-to-End Platform for Human Pluripotent Stem Cell Manufacturing.
Pandey PR; Tomney A; Woon MT; Uth N; Shafighi F; Ngabo I; Vallabhaneni H; Levinson Y; Abraham E; Friedrich Ben-Nun I
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
